Reshad Jones isn't coming back early, either.
The Miami Dolphins safety will not have his four-game suspension for violating the NFL's policy on performance enhancing drugs lifted this week, despite earlier reports by some media, even as the NFL and NFL Players Association today are expected to announce a new policy, The Miami Herald has learned.
[Update: A source close to Jones confirms now that he's been told he's not returning early.]
Jones remains on the suspended list along with teammate Dion Jordan, about whom The Herald reported Tuesday would also not have his suspension lifted.
So why are the two Dolphins players still suspended while other players around the NFL, such as Denver receiver Wes Welker and Dallas safety Orlando Scandrick, are being informed they can report to work as early as Wednesday?
The players under the performance enhancing substance policy suspensions being allowed back before their suspensions run their course tested positive in the offseason for amphetemines, which under the old drug policy were treated the same as performance enhancers thus were subject to the same four-game suspension upon the first positive test.
Those players' offseason amphetemine positive tests now are dealt with differently under the new drug policy.
Now, players testing positive for amphetemines in the offseason will be remanded to the recreational drug policy which allows for extra testing and counseling upon a first positive test but not a suspension.
Inseason positives for amphetemines will be treated same as before -- meaning there will be suspensions upon a first positive test result.
The fact neither Jones nor Jordan fall under the group who tested positive for amphetemines and will remain suspended suggests they tested positive for something other than amphetemines.
Both Jordan and Jones can return to the Dolphins on Sept. 29 -- one day after the team plays its fourth game of the season. The Dolphins will play Kansas City this weekend and Oakland on Sept. 28 before the players are allowed to return.